CTRI Number |
CTRI/2023/07/055680 [Registered on: 25/07/2023] Trial Registered Prospectively |
Last Modified On: |
22/06/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Ayurveda |
Study Design |
Randomized, Parallel Group Trial |
Public Title of Study
|
Effect of Shatapushpa Tail Uttarbasti & Sharpunkha Ghan Vati in the treatment of Vandhyatva (Infertility due to Anovulation) |
Scientific Title of Study
|
Comparative Study of Shatapushpa Tail Uttarbasti & Sharpunkha Ghan Vati in the management of Vandhyatva (Anovulation) |
Trial Acronym |
CSMV |
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Kanchan Choyal |
Designation |
P.G. Scholar |
Affiliation |
Post Graduate Institute of Ayurved Jodhpur, Rajasthan |
Address |
P.G. Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan
India
Jodhpur RAJASTHAN 342037 India |
Phone |
7734842989 |
Fax |
|
Email |
dr.kanchanchoudhary121@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Rashmi Sharma |
Designation |
Associate Professor |
Affiliation |
Post Graduate Institute of Ayurved Jodhpur, Rajasthan |
Address |
P.G. Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan
India
Jodhpur RAJASTHAN 342037 India |
Phone |
9166607559 |
Fax |
|
Email |
vd_rashmi11@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Dr Kanchan Choyal |
Designation |
P.G. Scholar |
Affiliation |
Post Graduate Institute of Ayurved Jodhpur, Rajasthan |
Address |
P.G. Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan
India
Jodhpur RAJASTHAN 342037 India |
Phone |
7734842989 |
Fax |
|
Email |
dr.kanchanchoudhary121@gmail.com |
|
Source of Monetary or Material Support
|
Post Graduate Institute of Ayurved, Jodhpur, Rajasthan |
|
Primary Sponsor
|
Name |
Post Graduate Institute of Ayurved, Jodhpur, Rajasthan |
Address |
P.G. Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, INDIA |
Type of Sponsor |
Research institution and hospital |
|
Details of Secondary Sponsor
|
Name |
Address |
Dr Kanchan Choyal |
P.G. Department of Prasuti Tantra Evam Stri Roga, Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, INDIA |
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Kanchan Choyal |
Post Graduate Institute of Ayurved ,Jodhpur, Rajasthan |
P.G. Department of Prasuti Tantra Evam Stri Roga(OPD no. 5),Post Graduate Institute of Ayurved, Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur, Rajasthan, INDIA Jodhpur RAJASTHAN |
7734842989
dr.kanchanchoudhary121@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee, Post Graduate Institute of Ayurved Jodhpur, Rajasthan |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:N970||Female infertility associated withanovulation. Ayurveda Condition: Female infertility, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Comparator Arm | Drug | Classical | | (1) Medicine Name: Sharpunkha Ghan Vati, Reference: Ras Ratan Samuchaya 22/51-52, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: tds, Bhaishajya Kal: Abhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Godugdh), Additional Information: - | 2 | Comparator Arm | Procedure | - |  उतà¥à¤¤à¤°-बसà¥à¤¤à¤¿ | (Procedure Reference: Kashyap Samhita /Shatapushpa Shatawari Kalp /5-17, Procedure details: ï‚·Prior to administration of Uttarabasti, Kosthashodhana will be done in all patients by giving Erandabrushtaharitaki 5gm at bedtime with hot water. Just before the main procedure Snehan with Tila Taila for 10 min and Nadisweda will be performed for 5 min below umbilicus and both lower limbs. Later on after Yoni Prakshalana with Triphala Kwath, Shatapushpa Tail Uttarabasti in the dose of 5 ml intrauterine just above the internal os with IUI (Intra Uterine Insemination) cannula will be given. A) (1) Medicine Name: Shatapushpa Tail, Reference: Kashyap Samhita /Shatapushpa Shatawari Kalp /5-17, Route: Vaginal, Dosage Form: Taila, Dose: 5(ml), Frequency: od, Duration: 2 Months |
|
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
40.00 Year(s) |
Gender |
Female |
Details |
1. Patient having complaint of failure to conceive (due to Anovulation) within one or more year of regular unprotected coitus. 2. Age groups-18 to 40 years 3.Primary or secondary infertility with Anovulatory factors. |
|
ExclusionCriteria |
Details |
1.Infertility due to other factor like uterine factor, cervical factor, tubal factor, peritoneal factor.
2.Infertility due to abnormality in male partner.
3.Patient suffering from chronic diseases like Hypertension, Diabetes mellitus, Malignancy, Thyroid disorder, Severe anaemia, Tuberculosis etc.
4.Patient suffering from Hepatitis B, sexually transmitted diseases, human immunodeficiency virus (HIV).
5.Congenital anatomical defect of female genital organ
6.Surgical factors like Ovarian tumour, Ovarian endometrioma, etc.
7.Contraindication of Uttar Basti (like Genital tract infection, heavy bleeding, etc.) |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
Case Record Numbers |
Blinding/Masking
|
Open Label |
Primary Outcome
|
Outcome |
TimePoints |
Improvement in Dominant follicle size & Endometrial thickness. |
Improvement in Dominant follicle size & Endometrial thickness. |
|
Secondary Outcome
|
Outcome |
TimePoints |
Improvement in Interval of menstrual cycle, Duration of Bleeding, Dyspareunia |
60 days |
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2/ Phase 3 |
Date of First Enrollment (India)
|
01/09/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
In randomised comparative clinical trial on 30 diagnosed vandhyatva (female Infertility) w.s.r. Anovulatory factor. Female Patients of child Bearing age (18-40yrs) having active married life minimum 1 year and suffering from Infertility with at least 2 or more consecutive anovulatory cycles were included. Female Patients having age less than 18years and more than 40years and Congenital deformities , infectious diseases of reproductive tract like tuberculosis, Sexually transmitted diseases and carcinoma, DM, HIV, HTN were excluded. Group A patients were given with Sharpunkha Ghan Vati in a dose of 500 mg tds for 7 days for 2 month. Group B patients were given with Shatapushpa Tail Uttaarbasti 5 ml for 2 consecutive cycles.
Conclusion: In Nut cell, it can be concluded that Shatapushpa tail Uttarbasti is more effective compared to Sharpunkha Ghan Vati. Final conclusion of the study will be arrived at only after completion of the study. |